
Catalog #RT60
Retatrutide
60 MG
Purity
≥98%
Storage
-20°C
Availability
1 In Stock
Select Research Tier:
Batch-tested · Research-grade purity · Certificate of Analysis included
Quantity:
Line Total:
$260.00
productDetail.bacteriostaticWater
productDetail.bacteriostaticDesc
Technical Research Description
Retatrutide is a first-in-class triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. This unimolecular tri-agonist demonstrates balanced activity across all three receptor systems, enabling research into synergistic metabolic pathway modulation that cannot be achieved with single or dual agonists.
Simplified Explanation
This is a groundbreaking "triple-action" peptide that activates three different hormone receptors at once. It's the first compound of its kind that combines GLP-1, GIP, and glucagon receptor activation in a single molecule. Researchers are exploring how this triple approach affects energy balance and metabolism.
For Research Use Only
DISCLAIMER: This product is sold for research purposes only. Not for human consumption.
By purchasing, you confirm that you are a qualified researcher or represent a research institution, and that this product will be used solely for in-vitro research or lawful scientific study.
Certificate of Analysis (COA)
THIRD-PARTY VERIFIEDIndependent third-party HPLC and mass spectrometry analysis is provided for every batch.
Customer Reviews
No reviews yet — be the first to share your experience.
